Partial epilepsy Trials in Bethesda, United States
Conditions / Partial epilepsy / Bethesda, United States
Clinical trials for Partial epilepsy investigate a range of treatment strategies and patient populations.
17 total trials for this combination
Showing top 10 of 17 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03478852 | Investigating Epilepsy: Screening and Evaluation | RECRUITING | — |
| NCT00908349 | Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Epilepsy | COMPLETED | PHASE3 |
| NCT00465517 | A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures | COMPLETED | PHASE2 |
| NCT01397968 | Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures | COMPLETED | PHASE2 |
| NCT01281956 | PRX-00023 Therapy in Localization-Related Epilepsy | TERMINATED | PHASE2 |
| NCT05067634 | Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures | RECRUITING | PHASE3 |
| NCT01496612 | Buspirone Therapy for Localized Epilepsy | TERMINATED | PHASE2 |
| NCT00988429 | Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures | COMPLETED | PHASE3 |
| NCT02535091 | Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures | COMPLETED | PHASE3 |
| NCT01866111 | A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures | COMPLETED | PHASE2 |